Union Korea Pharm Co Ltd (080720)

KOSDAQ

Currency in KRW

2,725

0(0.00%)

Closed·07:29:59

Fair Value

Unlock Value

Day's Range

2,725

3,070

52 wk Range

2,450

5,910

080720 Financial Summary

A brief financial summary of Union Korea Pharm Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio0

Price/Book0

Debt / Equity1,467.64%

Return on Equity-165.11%

Dividend Yield0.00%

EBITDA-15.73B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

61,293.49

63,169.01

51,279.94

Gross Profit

aa.aa

23,916.98

20,780.65

14,124.18

Operating Income

aa.aa

1,271.42

-14,681.93

-18,609.76

Net Income

aa.aa

-932.02

-18,156.3

-20,872.13

Balance Sheet

Total Assets

aa.aa

112,522.76

94,425.3

74,900.21

Total Current Liabilities

aa.aa

58,992.21

59,009.46

63,949.42

Total Equity

aa.aa

48,612.29

30,323.98

8,249.36

Cash Flow

Levered Free Cash Flow

aa.aa

-13,368.17

-7,528.16

13,353.3

Cash from Operations

aa.aa

-5,063.01

1,362.27

415.21

Cash from Investing

aa.aa

-3,527.75

-2,108.15

-821.41

Cash from Financing

aa.aa

-6,024.71

1,338.28

-1,875.64

Net Change in Cash

aa.aa

-14,647.16

566.84

-2,254.28

* In Millions of KRW (except for per share items)

Earnings

Latest Release

Aug 13, 2025

EPS / Forecast

-568.00 / --

Revenue / Forecast

10.15B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Union Korea Pharm's earnings for the latest quarter?

The Union Korea Pharm EPS (TTM) is -2,864.05. Union Korea Pharm reported sales of 10,151.66, net income of -4,105.96, and EPS of -568.00 for the latest quarter.

What was Union Korea Pharm's net income for the latest quarter?

Union Korea Pharm's net income for the latest quarter was -4,105.96.

How did Union Korea Pharm's performance compare year-over-year in the latest quarter?

The company's revenue moved from 12,617.41 in the previous quarter to 10,151.66 in the latest quarter, and net income moved from -2,560.85 to -4,105.96 compared to the previous quarter.

What is Union Korea Pharm's net profit margin on a TTM basis?

Union Korea Pharm's trailing twelve months (TTM) net profit margin is -40.70%.

How does Union Korea Pharm's debt to equity ratio compare to industry standards?

Union Korea Pharm's total debt-to-equity ratio is 1,467.64%.

What is Union Korea Pharm's return on investment on a TTM basis?

Union Korea Pharm's trailing twelve months (TTM) return on investment (ROI) is -165.11%.

Did Union Korea Pharm gain or lose cash last quarter?

In the latest quarter, Union Korea Pharm's net change in cash was -1,462.98 million.

What were Union Korea Pharm's total assets and liabilities in the latest quarter?

As of the latest quarter, Union Korea Pharm reported total assets of 66,755.08 million and total liabilities of 44,512.85 million.

How has Union Korea Pharm's total revenue grown this year?

Union Korea Pharm's total revenue was 12,617.41 in the previous quarter and 10,151.66 in the latest quarter.

What is Union Korea Pharm's gross margin on a TTM basis?

Union Korea Pharm's trailing twelve months (TTM) gross margin is 21.43%.

What was Union Korea Pharm's revenue per share for the latest quarter?

Union Korea Pharm's revenue per share for the latest quarter was 14,644.66.

NSE 30

5,126.80

-25.56

-0.50%

NSE All Share

140,557.23

-691.52

-0.49%

US 30

45,601.70

+36.6

+0.08%

US 500

6,502.00

+20.6

+0.32%

FTSE 100

9,216.82

-38.68

-0.42%

DAX

24,039.92

-6.29

-0.03%

South Africa Top 40

94,234.59

-127.83

-0.14%

Market Movers

Name	Last	Chg. %	Vol.
Champion Brew	17.30	-4.42%	201.05M
Access Holdings	27.00	-0.74%	102.18M
Guaranty Trust Holding	92.05	-3.11%	96.45M
Sterling Bank	8.000	0.00%	90.82M
First HoldCo	32.55	+0.15%	46.26M
Fidelitybk	21.300	-0.47%	33.50M
Aradel Holdings	510.00	0.00%	6.97M

Name	Last	Chg. %	Vol.
SCOA Nigeria	6.050	+10.00%	150.06K
Rtbriscoe	3.36	+9.80%	1.39M
Nem	31.200	+7.96%	1.74M
Nigerian Exchange	57.80	+7.94%	778.80K
McNichols	3.80	+7.04%	635.93K
Austin Laz	2.90	+6.62%	486.46K
Cutix	3.690	+5.43%	5.46M

Name	Last	Chg. %	Vol.
International Energy Insurance	3.29	-9.62%	2.60M
Omatek Ventures	1.32	-8.97%	1.53M
Ellah Lakes	13.68	-8.49%	11.65M
Royalex	2.00	-6.98%	7.12M
Sunu Assurances	5.54	-6.42%	1.33M
Dangote Sugar	58.00	-5.54%	1.65M
Secure Electronic Tech	0.90	-5.26%	15.17M

Trending Stocks

Name	Last	Chg. %	Vol.
VFD PLC	11.00	0.00%	3.68M
Mutual Benefits Assurance	3.90	-3.94%	11.12M
Ellah Lakes	13.68	-8.49%	11.65M
Guaranty Trust Holding	92.05	-3.11%	96.45M
MTN Nigeria	435.00	0.00%	719.13K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaa Aaaa	5,379.30	+47.85%	7,953.30
Aaa Aaaaaaaaaaaaaaa	520.20	+34.64%	700.40
Aaa Aaaaaaaaaa	1,870.00	+33.66%	2,499.44
Aaaa Aa	151.80	+28.97%	195.78
Aa Aa Aaa	640.00	+22.20%	782.08
Aaaaaaaaaaaa Aaaa	70.20	+19.18%	83.66

Name	Last	Upside	Fair Value
Aaaaa Aaaaa Aaaa	5,379.30	+47.85%	7,953.30
Aaa Aaaaaaaaaaaaaaa	520.20	+34.64%	700.40
Aaa Aaaaaaaaaa	1,870.00	+33.66%	2,499.44
Aaaa Aa	151.80	+28.97%	195.78
Aa Aa Aaa	640.00	+22.20%	782.08
Aaaaaaaaaaaa Aaaa	70.20	+19.18%	83.66

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Union Korea Pharm Co Ltd (080720)

080720 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Union Korea Pharm's earnings for the latest quarter?

What was Union Korea Pharm's net income for the latest quarter?

How did Union Korea Pharm's performance compare year-over-year in the latest quarter?

What is Union Korea Pharm's net profit margin on a TTM basis?

How does Union Korea Pharm's debt to equity ratio compare to industry standards?

What is Union Korea Pharm's return on investment on a TTM basis?

Did Union Korea Pharm gain or lose cash last quarter?

What were Union Korea Pharm's total assets and liabilities in the latest quarter?

How has Union Korea Pharm's total revenue grown this year?

What is Union Korea Pharm's gross margin on a TTM basis?

What was Union Korea Pharm's revenue per share for the latest quarter?

Trending Stocks